Eco R1 Capital, LLC Sage Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $28.9 Million - $43 Million	-940,636 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $34.9 Million - $44.3 Million	940,636 New	940,636 $40 Million
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $4.53 Million - $13.4 Million	-173,364 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $10.4 Million - $26.8 Million	173,364 New	173,364 $12.5 Million

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.